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Background: The number of diagnosed cases of Chlamydia trachomatis infection has been increasing in the past
years in Norway although the testing rate has been relatively stable. The aim of this study was to measure the
prevalence of genital Chlamydia trachomatis in young men and women in one county in Norway and determine
associated factors in order to better target preventive measures.
Methods: We mailed to a random sample of 10 000 persons aged 18–25 in Rogaland county a mail-back urine
sample kit and a self-administered questionnaire with questions on socio-demographic details, health seeking
behaviour and symptoms of and history of sexually transmitted diseases. Associations between current Clamydia
trachomatis infection and the above mentioned factors were studied by multiple logistic regression.
Results: The response rate among women was 18.9% (930/4923) and 11.9% (605/5077) among men. The
prevalence of Chlamydia trachomatis infection was 5.8% (95% CI 4.5-6.8) among women and 5.1% (95% CI 3.8-6.8)
among men. For men a greater number of partners during the last year (p for trend< 0.001), and living in a
municipality without a local youth clinic increased the odds of infection (OR 8.6, 95% CI 2.2-33.9). For women a
greater number of partners during the last year (p< 0.001) and not having consulted a family doctor for STIs (OR
2.1 95% CI 1.1-4.2) were positively associated with infection while not having a previous Chlamydia trachomatis
diagnosis decreased the odds of having this infection (OR 0.3, 95% CI 0.2-0.7).
Conclusion: Our results indicate the importance of having a visible youth clinic in each municipality. It also
suggests targeting women who have had a previous Chlamydia trachomatis infection diagnosed before.Background
Control of genital Chlamydia trachomatis infection
(hereafter: chlamydia) requires a range of activities,
among those the promotion of safer sex and condom
use, and early diagnosis and treatment [1]. Despite major
efforts to increase the condom use and testing activity
among young men and women in Norway, the testing
rate has been relatively stable, 53 per 1000 population in
2000 and 51 per 1000 population in 2010, and the num-
ber of diagnosed chlamydia cases has been increasing
[2,3]. The aim of this study was to measure the preva-
lence of chlamydia in men and women aged 18–25 years* Correspondence: hilde.klovstad@fhi.no
1Norwegian Institute of Public Health, PO box 4404, Nydalen, Oslo 0403,
Norway
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© 2012 Kløvstad et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the orin Norway and determine associated factors in order to
better target preventive measures.
Methods
Study design and study population
We conducted a cross sectional study among a random
sample of 10 000 persons aged 18–25 years selected
from the national population register with residence in
one of Norway’s 19 counties, Rogaland (41 519 persons
with birth year 1980–1987 in this area). This cross sec-
tional study was part of a trial on the efficacy of home
sampling for chlamydia versus no intervention in testing,
diagnosing and treating chlamydia in this age group. We
used the unique personal identity number of individuals
living in Norway to randomize participants. An invita-
tion was sent by mail to all10 000 with a mail back urine
sample kit and a self-administered questionnaire. Thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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an invitation to take a home test free of charge, a urine
container, instructions on how to obtain a first void
urine sample and a prepaid return envelope. The ques-
tionnaire included questions on socio-demographic
details (age, sex, marital status, education, occupation,
country of birth), health seeking behaviour, sexual be-
haviour (number of partners, contraception use at last
sexual intercourse with steady and non-steady partner)
and symptoms at the time of testing (discharge, endocer-
vical bleeding, pelvic pain, urethral itching, dysuria) and
history of sexually transmitted infections (STI). The par-
ticipants were requested to send the urine sample by
mail to the local hospital and the questionnaire to the
Norwegian Institute of Public Health within three
months after invitation. The study period lasted for three
months in the period February- May in 2006.
Information on outcomes
A participant was defined as a chlamydia case if the
urine test was positive for chlamydia within the study
period. All samples were analyzed with BD ProbeTec
Chlamydia Amplified DNA assay (Becton, Dickinson,
Franklin Lake, New Jersey, USA) [4-6].
Statistical analysis
Confidence intervals (CI) for the prevalence of Chla-
mydia infection were calculated using Wilson’s method.
Pearson’s chi-squared tests were used for bivariate ana-
lyses of nominal data. Interval data were compared using
Student’s t-tests for unpaired samples.
Independent associations between the studied factors
and the odds of having chlamydia were studied in mul-
tiple logistic regression. Crude and adjusted odds ratios
(OR) were calculated.
The strongest predictors were identified using back-
ward elimination procedure in multiple logistic regres-
sion. The selection of variables was based on the results
of the likelihood ratio tests.
All analyses were performed using SPSS 14.0 (SPSS
Inc., Chicago, IL).
Ethics
The research project was approved by the Regional
Committee for Medical and Health Research Ethics
(REK), South-East region, in January 2006.
Results
A total number of 1670 returned the questionnaire and
submitted a urine sample for chlamydia testing during
the study period, response rate 16,7%. Among those, we
included the 1568 that were at risk, i.e. reported ever
having had sexual intercourse. Due to missing values
only 1535 were included. Altogether 930 (60%) of therespondents were women, response rate 18,9% . Among
men the response rate was 11.9% (605/5077). The re-
sponse rate was higher in the age group 22–25 years
(16.6%, 828/4995) than in the age group 18–21 years
(14.1%, 707/5005). The mean age was 22.0 (SD= 2.2)
years for men and 21.6 (SD= 2.2) years for women
(t (1533) = 3.44, p< 0.001).) Only 5.6% of the participants
were non-Norwegians, with continents of birth equally
distributed between Europe/North America and other
continents (Asia, South and Central America, Africa and
Oceania) (Table 1).
Sexual behaviour, use of health care services and self
reported sexually transmitted diseases
Mean age for sexual debut for women was 16.7 years
(range12-24) and for men 17.2 years (range 11–25).
Women reported having their first sexual intercourse 6.5
(95% CI 4.0-9.0) months earlier than men (t (1507) = 5.09,
p< 0.001). More than half of the participants had a
steady partner at the time of the survey. Close to sixty
percent reported having had no more than one sexual
partner during the last year while 17% reported four sex-
ual partners or more for the same period. Men had more
sexual partners during the last year than women (χ(1)
2
=10.99, p for linear trend <0.001) although no difference
in lifetime numbers of partners was observed (χ(1)
2 =1.85,
p for linear trend =0.174). Only 17,4% reported having
used a condom at last sexual intercourse with a casual
partner, 31% used hormonal contraceptives and 15%
used no contraceptive methods (Table 1).
More women than men had ever consulted the doctor
to get tested for an STI (55% vs 32%; χ(1)
2 =6.85,
p <0.001). 37 percent answered “do not know” to the
question whether there was a youth clinic in their muni-
cipality. Women were more aware about the youth
clinics than men (χ(1)
2 =40.7, p <0.001), and were also
more likely to use the youth clinics (women 34%, men
11%, χ(1)
2 = 101.22, p <0.001). Women were more likely
than men to previously have been tested (women 54%,
men 27% χ(1)
2 =118.70, p <0.001) and diagnosed with
Chlamydia infection (women 16,2% and men 9,4%) χ(1)
2
=14.95, p <0.001). 7% reported a history with genital
warts, no gender difference (Table 1).
Prevalence of chlamydia and factors associated with
disease
The chlamydia prevalence was 5.5% (85/1535, 95% CI
4.5-6.8)), 5.8% among women (54/930, 95% CI) and 5.1%
among men (31/605, 95% CI 3.8-6.8). In the age group
18–21 the chlamydia prevalence was 6.5% (46/707, 95%
CI 4.9-8.6) and in the age group 22–25 4.7% (39/828, CI
3.5-6.3). The chlamydia prevalence was 5.5% (80/1451,
95% CI 4.5-6.8) among Norwegian born and 0% among
participants born in Europe and North America. Among
Table 1 Prevalence of genital chlamydia infection and socio-demographic factors and health care utilisation, sexual
behaviour and self-reported STIs among men and women aged 18–25 years in Rogaland, Norway. N=1535
Men (n = 605) Women (n= 930)
n/N % 95% CI n/N % 95% CI
Age 18-21 16/254 6.3 3.9-10.0 30/453 6.6 4.7-9.3
22-25 15/351 4.3 2.6-6.9 24/477 5.1 3.4-7.4
Marital status Single 30/550 5.5 3.8-7.7 54/817 6.6 5.1-8.5
Married 1/55 1.8 0.3-9.6 0/113 0 0-3.2
Education, years ≤14 29/490 5.9 4.2-8.4 45/675 6.7 5.0-8.8
15+ 2/115 1.7 0.5-6.1 9/255 3.5 1.9-6.6
Occupation Employed 18/339 5.3 3.4-8.2 23/336 6.8 4.6-10.1
Unemployed 4/27 14.8 5.9-32.5 4/37 10.8 4.3-24.7
Student/pupil 8/197 4.1 2.7-7.8 20/479 4.2 2.7-6.4
Other/Unknown 1/42 2.4 0.4-12.3 7/78 9.0 4.4-17.4
Country of birth Norway 28/575 4.9 3.4-7.0 52/876 5.9 4.6-7.7
Europe/North America 0/13 0 0-22.8 0/29 0 0.11.7
Other countries 3/17 17.6 0.4-12.3 2/29 8.8 3.0-23.0
Presence of a youth clinic in municipality Yes 20/307 6.5 4.3-9.9 38/589 6.5 4.7-8.7
No 5/15 33.3 15.2-58.3 1/50 2.0 0.4-10.5
Do not know 6/283 2.1 1.0-4.6 15/291 5.2 3.2-8.3
Using youth clinic services Yes 2/66 3.0 0.8-10.4 23/312 7.4 5.0-10.8
No 29/539 5.4 3.8-7.6 31/618 5.0 3.6-7.0
Consulted a family doctor on STI Yes 14/191 7.3 4.4-11.9 33/514 6.4 4.6-8.9
No 17/414 4.1 2.6-6.5 21/416 5.0 3.3-7,6
Number of partners during last year 0 1/24 4.2 0.7-20.2 0/14 0 0-21.5
1 2/303 0.7 0.2-2.4 15/563 2.7 1.6-4.4
2-3 11/154 7.1 4.0-12.3 19/222 8.6 5.6-13.0
4-5 9/66 13.6 7.3-23.9 12/83 14.5 8.5-23.6
5+ 8/58 13.8 7.2-24.9 8/48 16.7 8.7-29.6
Total number of partners 1 0/114 0 0-3.3 0/184 0 0-2.1
2-3 3/130 2.3 0.8-6.6 5/212 2.4 1.0-5.4
4-5 1/103 1.0 0.2-5.3 5/157 3.2 1.4-7.2
6-10 11/124 8.9 5.0-15.2 23/215 10.7 7.2-15.5
10+ 16/134 11.9 7.5-18.5 21/162 13.0 8.6-19.0
Previoulsy tested for chlamydia Yes 11/161 6.8 3.9-11.8 35/510 6.9 5.0-9.4
No 20/444 4.5 2.9-6.9 19/420 4.5 2.9-7.0
Previously diagnosed with chlamydia Yes 4/57 7.0 2.8-16.7 19/152 12.5 8.2-18.7
No 27/548 4.9 3.4-7.1 35/778 4.5 3.5-6.2
Previoulsy diagnosed with genital warts Yes 3/40 7.5 2.6-19.9 1/64 1.6 0.3-8.3
No 28/565 5.0 3.5-7.1 53/866 6.1 4.7-7.9
Previously diagnosed with genital herpes Yes 2/2 100 0.34-100 0/16 0 0-19.4
No 29/603 4.8 3.4-6.8 54/914 5.9 4.6-7.6
Presence of symptoms Yes 10/83 12.0 6.7-20.8 20/329 6.1 4.0-9.2
No 21/522 4.0 2.7-6.1 34/601 5.7 4.1-7.8
Sex with a person of the same sex Yes 0/28 0 0-12.1 5/65 7.7 3.3-16.8
No 31/577 5.4 3.8-7.5 49/865 5.7 4.3-7.4
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Table 1 Prevalence of genital chlamydia infection and socio-demographic factors and health care utilisation, sexual
behaviour and self-reported STIs among men and women aged 18–25 years in Rogaland, Norway. N=1535 (Continued)
Method with casual partner No contraception 12/136 8.8 5.1-14.8 10/99 10.1 5.6-17.6
Condom 7/135 5.2 2.5-10.3 9/134 6.7 3.6-12.2
Hormonal 8/135 5.9 3.0-11.3 29/345 8.4 5.9-11.8
Other 4/199 2.0 0.8-5.0 6/352 1.7 0.8-3.7
Method with long-term partner No contraception 8/114 7.0 3.6-13.2 11/129 8.5 4.8-14.6
Condom 4/86 4.7 1.8-11.4 1/83 1.2 0.2-6.5
Hormonal 15/331 4.5 2.8-7.3 34/588 5.8 4.2-8.0
Other 4/74 5.4 2.1-13.1 8/130 6.2 3.2-11.7
Constant partner Yes 8/297 2.7 1.4-5.2 22/520 4.2 2.8-6.3
No 23/308 7.5 5.0-11.0 32/410 7.8 5.6-10.8
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lence was 11.9% (5/42, 95% CI 5.2-25.0). The five chla-
mydia cases came from Asia (2) South and Central
America(2) and Oceania (1).
In a multivariate analysis the following variables
remained associated with chlamydia infections: For men
a greater number of partners during the last year
increased the odds of infection (p< 0.001), and not hav-
ing a local youth clinic present increased the odds of in-
fection by 8.6 times (OR 8.6, 95% CI 2.2-33.9) compared
to those who reported having a local youth clinic in their
home municipality. Only 15 reported not having a local
youth clinic. For women a greater number of partners
during the last year was associated with increased odds
of infection (p< 0.001) while having no previous chla-
mydia diagnosis decreased the odds of infection com-
pared to those who had been diagnosed with chlamydia
before(OR 0.3, 95% CI 0.2-0.7). Those who had not pre-
viously consulted a family doctor for STIs had 2.1 (95%
CI 1.1-4.2) higher odds of infection compared to those
who had previously consulted their family doctor for
STIs (Table 2).
Discussion
This study is the only population based study measuring
chlamydia and associated factors in young Norwegian
men and women in one county where the study sample
is drawn from the national population register, which
includes the entire population, and not from a selected
group of individuals. It is also among the rare prevalence
studies were home sampling by postal recruitment was
used. We found a chlamydia prevalence of 5.5% in our
population. The likelihood of infection increased with a
greater number of partners. Among women, those with
a previous chlamydia diagnosis (and those who had not
previously consulted their family doctor on STIs) were
more likely to have a current infection. Among men the
odds of infection increased by 8.6 times if they believed
there was no local youth clinic present. The majority didnot use condom at last sexual intercourse with a casual
partner.
Prevalence of chlamydia, and other self reported STIs
We measured a chlamydia prevalence of 5.5%. Other
chlamydia prevalence surveys in Norway have found
from 1 to 9% depending on the basis of their population.
[7,8] [9-13]. A study among all high school graduates
(18 year olds) in one Norwegian municipality found a
chlamydia prevalence of 2% among those who had had
their sexual debut [9]. Another prevalence study among
Norwegian male students aged 18–30 recruited at stu-
dent campus and students health centres measured a
chlamydia prevalence of 7.8% [10]. A home based chla-
mydia prevalence survey among patients 18–29 of age
listed at a general practice in Oslo gave a chlamydia
prevalence of 3% [7]. A chlamydia prevalence of 9% was
found among young girls 16–19 years seeking youth
clinic for hormonal prevention [14] and 6% among
women (16–24) seeking abortion [15]. Our results are in
the mid-range of what is found in other publications
from Norway, lower than in the populations seeking
health care, but higher than most other studies con-
ducted in different populations outside the health care
system. Population based studies offering home sam-
pling for chlamydia outside Norway has shown a preva-
lence ranging from 1 to 7%[16] [17-20].
Seven percent reported a history of genital warts in
our sample. This is lower than reported from other Nor-
dic countries.[21].
Sexual behaviour and health care use
According to the national sexual behaviour studies in
Norway the age for sexual debut has been decreasing
from 1987 to 2002 when the median age was 17,5 years
for men and 17.1 years for women [22]. Another publi-
cation on decreasing trends for age for sexual debut
among Norwegian youth from the same time-period
reported median age for sexual debut to 18.0 years for
Table 2 Factors associated with genital chlamydia infection among men and women aged 18–25 years in Rogaland,
Norway
Sample characteristic n/N Crude OR 95%CI *Adjusted OR 95% CI p-value
Men
Presence of a local youth clinic <0.001
Yes 20/307 1 Reference 1 Reference
No 5/15 7.2 2.2-23.0 8.6 2.2-33.5
Do not know 6/283 0.3 0.1-0.8 0.3 0.1-0.7
Using youth clinic’s services 0.066
Yes 2/66 1 Reference 1 Reference
No 29/539 1.8 0.4-7.8 4.1 0.9-19.1
Number of partners during last year <0.001
0 1/24 6.5 0.6-74.9 6.2 0.5-78.2
1 2/303 1 Reference 1 Reference
2-3 11/154 11.6 2.5-52.9 11.2 2.4-52.5
4-5 9/66 23.8 5.0-112.9 28.6 5.8-142.0
More than 5 8/58 24.1 5.0-116.7 30.5 6.0-155.5
Women
Previously diagnosed with Chlamydia
Yes 19/152 1 Reference 1 Reference <0.001
No 35/778 0.3 0.2-0.6 0.3 0.2-0.6
Previously diagnosed with genital warts
Yes 1/64 1 Reference 1 Reference 0.071
No 53/866 4.1 0.6-20.2 6.5 0.8-49.1
Consulting family doctor on STI
Yes 18/352 1 Reference 1 Reference 0.027
No 36/578 1.2 0.7-2.2 2.1 1.1-4.2
Number of partners during last year
0 0/15 - - - - <0.001
1 15/563 1 Reference 1 Reference
2-3 19/222 3.4 1.7-6.9 3.2 1.6-6.5
4-5 12/83 6.2 2.8-13.7 6.5 2.8-14.7
More than 5 8/48 7.3 2.9-18.3 7.9 3.0-20.6
Estimated in multiple logistic regression. N = 1535.'
*adjusted odds ratios are adjusted for the variables in the table as a result of stepwise procedure, backwards elimination.
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among male students the median age for sexual debut
was 17.5[10]. A recent publication on sexual behaviour
among Nordic women reported a median age of 16 years
for the first intercourse for the Norwegian women
involved [24]. Our results do not differ much from these
other studies. We found a slightly lower mean age for
sexual debut among the men in our study. This could be
the result of a continuous decreasing trend. However, it
could also indicate that men with an earlier sexual debut
or who felt more at risk of infection were more likely to
take part in our study. Only 17% reported using condom
at last sexual intercourse with casual partner. This result
is supported by the National sexual behaviour studies
[22]. In the study among male students 76% reportednot using condom at last intercourse[10], The condom
use among young Norwegians is however less frequent
than reported from other European countries [25,26].
Factors associated with infection
A greater number of partners is well documented as a
risk factor for chlamydia[26-28]. Condom use[26,29] and
presence of genital symptoms[30] have by many been
documented as risk factors, but this is not universal. We
also found that having multiple partners was associated
with a positive test result, but condom use at last sexual
intercourse with non- steady partner and presence of
genital symptoms (discharge, endocervical bleeding, pel-
vic pain, urethral itching, dysuria) was not associated
with infection, neither was any of the socio-demographic
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cation, occupation, country of birth).
Among men, reporting that the home municipality lacked
a youth clinic was associated with chlamydia, indicating that
youth clinics may be a valuable contribution to lower the
community prevalence of chlamydia among men. This is
probably an indirect effect of diagnosing and treating young
women as these are the overwhelming majority of users of
these drop-in facilities that offer condoms and chlamydia
tests free of charge for young people up to the age of 20 years.
In Rogaland county, the majority of the municipalities do
offer a local youth clinic. Perhaps also the mere visibility of
such a clinic can contribute to a more protective behaviour
among men. The finding should, however, be interpreted
with caution because of the small group size reporting not
having a local youth clinic in their home municipality.
Close to half of the men in our survey did not know if
there was a youth clinic present in their municipality.
This group had a lower chlamydia prevalence, only 2.1%.
We may speculate that these men have less sexual risk
behaviour and therefore never have felt the need to find
out about youth clinics in their area. Alternatively, these
men were more likely to take part in the study and use
our mailed testing kits since they were not aware of the
youth clinic with testing facilities nearby.
Among women, we found that having had chlamydia
diagnosed previously was associated with an increased risk
of current infection. This is consistent with findings from
a substantial body of previous literature [31,32]. 63% of
the chlamydia positive women with a previous chlamydia
diagnosis in our study had changed their sexual partner
within the last 6 months. The temporal association be-
tween the previous infection and this positive test is, how-
ever, unknown. We can therefore not establish whether
the positive test result represents treatment failure, lack of
partner treatment or a new infection with a new sexual
partner. Many factors could contribute to this result. Our
results may indicate that sexual risk behaviour is persist-
ent and that a chlamydia diagnosis may not lead to behav-
ioural change. It highlights the need for guidance on safe
sexual behaviour at the time of treatment, more careful
partner tracing and treatment and a special need to target
women with a previous chlamydia diagnosis in screening.
On the other hand, women who had consulted their fam-
ily doctor on STIs were less likely to have a current infec-
tion than those who had not consulted their family
doctor. Possible explanations could be that women who
consult their family doctor for STIs are those with less
sexual risk behaviour or that they in fact have received
good guidance on safe sexual behaviour from their doctor.
Limitations
This cross sectional study was part of a clinical trial of a
postal screening system for chlamydia in Norway. Onlythose who wanted to have a chlamydia test taken answered
the questionnaire. The response rate is therefore lower than
what would have been expected if the participants would
only have to answer a questionnaire. The uptake of the
screening offer was also lower than anticipated and what
has been the case in similar studies[16-18]. The low re-
sponse rate raises the concern of a potential selection bias
in our results. It is a cause for concern regarding the validity
of the prevalence estimates. As we have no information on
the non-responders, including their chlamydia status, we
will not know if reasons not to participate in the study are
the same as factors associated with infection. However,
regarding the association between chlamydia and risk fac-
tors within the group of respondents, the overall response
rate is less of a concern. The low response rate would lead
to biased associations only if participation was associated
with both chlamydia and the risk factors in question, which
is more unlikely.
The rather low number of participants and thereby chla-
mydia cases in our study gives the study limited power to
detect associations between infection and exposures. We
can therefore not exclude other associations than those
detected by our study.
Questionnaires were filled out at the same time as the
home sample was submitted. With this cross sectional
study design we are not allowed to determine a causative
effect of the different factors associated with infection.
The relatively long recall period could cause misreporting
of own risk behaviour. However, differential misclassifica-
tion is avoided since infectious status was not known at
the time the participants fill out the questionnaires.
On the other hand, by using postal recruitment and
allowing participants to take the chlamydia test at home,
we might have reached a broader part of the population
than those seeking the health care service believing they
are at risk.Conclusion and recommendations
Young Norwegian men and women have their sexual
debut at an early age and the majority do not use condom
when having casual sex. We found a chlamydia prevalence
of 5.5% in our population. The probability of infection
increased with a greater number of partners, and among
men the odds of infection increased if their home munici-
pality lacked a youth clinic. For women having a previous
chlamydia diagnosis increased the probability of infection
while having previously consulted their family doctor
decreased the odds of infection.
Only a very low proportion of the men in our sample
had ever visited their local youth clinic. Our results indi-
cate the importance of having a visible youth clinic in
each municipality. It also suggests targeting women with
a previous chlamydia diagnosis.
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